Member list of Oslo Cancer Cluster

Below you find a list of all members of Oslo Cancer Cluster in alphabetical order.

Results 1 - 20 out of 83 displayed.
 
Sort direction:
Sort direction:
1  2  3  4  5 »
AbbVie AS   
Fornebu, Norway
AbbVie AS is a research-based biopharmaceutical company. The company's mission is to develop and market advanced therapies in the areas of hepatitis C (HCV), neuroscience, immunology, oncology, etc.
Acapo AS   
Bergen, Norway
Acapo AS is a full-serviced IPR-firm focused in the maintenance of patents, design and trademark registrations.
AKERSHUS UNIVERSITETESSYKEHUS HF   
Lørenskog, Norway
Akershus University Hospital (Ahus) provides treatments that safeguards and promotes patients health. The hospital delivers specialist in somatic health care, mental health and substance abuse.
Amgen Norge   
Oslo, Norway
Amgen AB is active in clinical trials, medical information and scientific projects. The marketing department is responsible for disseminating information about marketed drugs for health professionals. Amgen has a broad portfolio of biotechnological drugs in the fields of therapy oncology, hematology, nephrology, osteoporosis and cardiology.
APIM Therapeutics AS   
Trondheim, Norway
APIM Therapeutics is developing a pipeline of peptide drugs that target PCNA-dependent stress responses in cancer cells. ATX-101, the lead drug candidate is currently being tested in a phase I clinical study in advanced cancer patients.
Arctic Pharma AS   
Oslo, Norway
Arctic Pharma AS is a privately held company, devoted to develop novel drugs and therapy in cancer and metabolic diseases.
Artemida Pharma   
Hertfordshire, United Kingdom
Artemida Pharma is a specialist consultancy business established by a group of drug development experts, to provide strategic drug development consultancy and project management to start-up, biopharma and mid-sized pharma companies. The company is a provider of end-to-end services, encompassing strategic clinical, regulatory and commercial expertise, along with a focus on technical pharmaceutical development of small molecules and biological agents.
Astellas Pharma   
Asker, Norway
Astellas Pharma Inc. is a research-oriented global pharmaceutical company operating in about 50 countries with a focus on ethical pharmaceuticals. The company focuses on the areas like urology, immunology, infectious diseases, oncology, neuroscience, etc.
AstraZeneca AS   
Oslo, Norway
AstraZeneca PLC engages in the discovery, development, and commercialization of prescription medicines for cardiovascular, gastrointestinal, neuroscience, infection, oncology, and respiratory and inflammation diseases worldwide. The company's principal products include Atacand for hypertension and heart failure; Crestor for managing cholesterol levels; Seloken/Toprol-XL for hypertension, heart failure, and angina; Nexium for acid reflux; Synagis for RSV, a respiratory infection in infants; Seroquel...
Balter Medical AS   
Bergen, Norway
Balter Medical aims to develop and commercialize medical applications of the Optical Transfer Theory, which is a mathematical modeling technique using digital photographic images (pictures) to understand the properties of the subject in the picture. The company has successfully developed a medical imaging device (BM-Dermatoscope) and a diagnostic algorithm [Optical Transfer Diagnosis (OTD)] for detecting anomalies in human tissue. The first BM-OTD application is a device and an algorithm to...
Bayer AS   
Oslo, Norway
Bayer AS's main activities consist of sale, service and marketing of the Bayer Group and Lanxess' products. The activities are divided into six operating units: pharmaceuticals, consumer health, crop science, animal health, Bayer Garden, Bayer Agency Business. Bayer Nordic has offices in Finland(Headquarters), Denmark, Sweden, Norway, Lithuania, Latvia and Estonia.
Bergen Teknologioverføring AS   
Bergen, Norway
Bergen Teknologioverføring AS (BTO) is the technology transfer office in Bergen, supporting ten research institutions in commercialization and technology transfer. BTO’s goal is to help researchers commercialise their research results to ensure that knowledge and inventions benefit individuals, society and industry.
BerGenBio ASA   
Bergen, Norway
BerGenBio is a clinical-stage oncology company advancing first-in-class, selective AXL kinase inhibitors as a potential cornerstone of combination therapy for multiple cancers. The company's lead product, Bemcentinib (BGB324) is a potent, selective and orally bioavailable AXL inhibitor and the most-advanced selective AXL inhibitor in clinical trials.
Birk Venture   
Oslo, Norway
Birk Venture is a venture capital firm specializing in early stage. The firm invests in small size and start-up companies with a unique technology. The company exclusively invests in the life science industry with a special focus on pharmaceuticals, biotechnology, diagnostics, medical devices and instruments, and consumer health.
Bristol-Myers Squibb Norway   
Lysaker, Norway
Bristol-Myers Squibb operates as a biopharmaceutical company, which engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of biopharmaceutical products. The company in Norway focuses on sales and services and also supports hospital clown.
Bryn Aarflot AS   
Oslo, Norway
Bryn Aarflot AS is a consulting firm, providing assistance to inventors, start-ups, companies and others within all areas of intellectual property law. The company's teams of lawyers and patent attorneys provide the service Level in IP advising through the process from innovation to commercialisation.
Calliditas Therapeutics AB   
Stockholm, Sweden
Calliditas Therapeutics is a specialty pharmaceutical company based in Stockholm, Sweden, focused on developing pharmaceutical products for patients with a significant unmet medical need in niche indications, in which the company can partially or completely participate in the commercialization efforts. The company is focused on the development and commercialization of the product candidate Nefecon, a unique formulation optimized to combine a time lag effect with a concentrated release of the...
Celgene AS   
Oslo, Norway
Celgene is an international biopharmaceutical company focused on discovering, bringing the development and marketing of innovative medicines which are particularly aimed at treatment of cancer, immune and inflammatory diseases.
Centre for Cancer Biomarkers (CCBIO)   
Bergen, Norway
The Centre for Cancer Biomarkers (CCBIO) at the Faculty of Medicine and Dentistry, University of Bergen is working on new cancer biomarkers and targeted therapy, and has a particular focus on mechanisms which show how cancer cells are affected by the micro-environment in the tumors, and what significance this has for cancer proliferation and poor prognosis.
Chiltern International AB   
Göteborg, Sweden
Chiltern International Limited, a contract research organization, provides clinical development, scientific services, and collaborative technologies for pharmaceutical and biotech companies.

1  2  3  4  5 »
© Biotechgate by Venture Valuation